Cargando…
536. Clinical Outcomes of Hospitalized COVID-19 Patients Treated with Remdesivir-NEAT ID 909REM Study
BACKGROUND: There are few real-world data on the use of remdesivir (RDV) looking at timing of initiation in relation to symptom onset and severity of presenting disease. METHODS: We conducted multi-country retrospective study of clinical practice and use of RDV in COVID-19 patients. De-identified me...
Autores principales: | Raffi, François, Arber, Nadir, Rokx, Casper, Assoumou, Lambert, Shah, Pallav L, De Castro, Nathalie, Bakhai, Ameet, Soriano, Alex, Mateu, Lourdes, Lumbreras, Carlos, Estrada, Vicente, Curran, Adrian, Sellier, Pierre-Olivier, Duffy, Annie, Fletcher, Carl, Mozaffari, Essy, Haubrich, Richard, Hodgkins, Paul, Pozniak, Anton |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644799/ http://dx.doi.org/10.1093/ofid/ofab466.735 |
Ejemplares similares
-
38. Remdesivir Treatment in Patients Hospitalized with COVID-19: A Comparative Analysis of In-Hospital All-Cause Mortality
por: Mozaffari, Essy, et al.
Publicado: (2021) -
PIN82 Real-World Utilization of Remdesivir in 2020: A Retrospective Cohort Study
por: Mozaffari, E., et al.
Publicado: (2021) -
Remdesivir Treatment in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): A Comparative Analysis of In-hospital All-cause Mortality in a Large Multicenter Observational Cohort
por: Mozaffari, Essy, et al.
Publicado: (2021) -
Comparative effectiveness research in COVID-19 using real-world data: methodological considerations
por: Read, Stephanie H, et al.
Publicado: (2021) -
POSB12 Association Between Remdesivir Treatment and In-Hospital All-Cause Mortality Among Patients Hospitalized with COVID-19
por: Mozaffari, E, et al.
Publicado: (2022)